Von Hippel-Lindau (VHL) syndrome is rare, autosomal dominant disorder, characterized by hypervascularised tumour formation in multiple organ systems. Vision loss associated with retinal capillary hemangioblastomas remains one of the earliest complications of VHL disease. The mortality of Vhl -/mice in utero restricted modelling of VHL disease in this mammalian model. Zebrafish harbouring a recessive germline mutation in the vhl gene represent a viable, alterative vertebrate model to investigate associated ocular loss-of-function phenotypes. Previous studies reported neovascularization of the brain, eye and trunk together with odema in the vhl -/zebrafish eye. In this study, we demonstrate vhl -/zebrafish almost entirely lack visual function. Furthermore, hyaloid vasculature networks in the vhl -/eye are improperly formed and this phenotype is concomitant with development of an ectopic intraretinal vasculature. Sunitinib, a multi tyrosine kinase inhibitor, market authorised for cancer, reversed the ocular behavioural and morphological phenotypes observed in vhl -/zebrafish. We conclude that the zebrafish vhl gene contributes to the endogenous molecular barrier that prevents development of intraretinal vasculature and that sunitinib can improve visual function and hyaloid vessel patterning while reducing abnormally formed ectopic intraretinal and choroidal vessels in vhl -/zebrafish.
Introduction
Retinal hemangioblastomas, tumours of retinal blood vessels, are a characteristic clinical feature of Von Hippel Lindau (VHL) syndrome, a rare, systemic disease associated with significant loss of vision [1] . These benign, hypervascularised tumours represent the earliest complication of VHL disease, occurring in more than half of VHL patients. Development of retinal hemangioblastomas is dependent on dysregulation of ocular angiogenesis. Ocular angiogenesis is a dynamic process, controlled by an intricate balance of pro-and antiangiogenic factors [2] . Imbalances can result in growth of abnormal, leaky vessels. VEGF isoforms and cognate receptors are key players which influence endothelial cell proliferation and migration during both developmental and pathological angiogenesis [3, 4] .
Pathological neovascularisation is a significant feature of blinding disorders including diabetic retinopathy, retinopathy of prematurity and neovascular age-related macular degeneration [5] . Oncogenes, tumour suppressor genes and disruptions in growth factor activity promote pathological ocular angiogenesis. In VHL disease, loss-of-function germline mutations in the tumour suppressor gene VHL and subsequent inactivation of the second wildtype allele leads to aberrant hypoxia inducible factor-1 (HIF-1) expression and the development of multi-systemic tumours [1] . HIF-1 is a master transcriptional regulator, vital for cellular adaptation to hypoxia. In the absence of functional VHL, HIF-α translocates to the nucleus, upregulates transcription of pro-angiogenic mediators including VEGF and its receptors, erythropoietin (EPO), EPO receptor (EPOR), multidrug resistance pump (MDR-1) transferrin, angiopoietin 1, glucose transporters (GLUT-1) and glycolytic enzymes [6, 7] .
Hypoxic pathways are well conserved between zebrafish and human making zebrafish a powerful model for hypoxia-related studies (Metelo et al., 2015) . Furthermore, functional studies from forward and reverse genetics show the molecular components that regulate vascular development are conserved between mammals and fish [8] [9] . Two vascular networks form within the zebrafish eye during embryonic development -the hyaloid vessels located in the anterior eye, and the superficial choroidal vasculature which overlies the retinal pigmented epithelium and is responsible for oxygenation of the photoreceptors [10] . In contrast to zebrafish larvae, the hyaloid network in the human eye undergoes a programmed regression to form the retinal vasculature [11, 12] .
A recessive vhl zebrafish model mimics some genetic and clinical hallmarks of VHL disease and provides a powerful model to study systemic and ocular-specific phenotypes linked to the absence of VHL signalling [13] . vhl -/zebrafish larvae display upregulated VEGF ligands (vegfaa, vegfab and vegfd) and receptors (flt-1, kdr and kdr-like) accompanied by ectopic cranial and intersegmental vasculature [14] . Aberrant expression of these HIF-target genes results in ectopic and leaky blood vessel formation in the trunk and eye, akin to pathological features observed in VHL patients [14] . Homozygous vhl -/zebrafish display pericardial and yolk oedema and typically die on or before day 13 due to cardiac or renal failure [13] .
Previous pharmacological studies blocking HIF2α in vhl -/rescued embryonic pathologic angiogenesis and prolonged survival [7] .
While the morphological vascular phenotypes of vhl -/zebrafish are characterised [7, [13] [14] [15] nothing is reported regarding the impact on visual function. Here, we identify and characterise an absent optokinetic response and a significantly reduced visual motor response in vhl -/-. We reaffirm the development of ectopic ocular blood vessels but clarify that this results from an attenuation of hyaloid vessels and the emergence of pathological ectopic intraretinal vessels in vhl -/larvae. We show a selective downregulation of vegfaa in vhl -/larval eyes following treatment with sunitinib malate, an anti-angiogenic compound approved for cancer treatment. Additionally, we demonstrate pharmacological improvement of visual function and normalisation of ocular vasculature in vhl -/following treatment. In summary, the vhl gene, by controlling vegfaa expression in the eye, prevents intraretinal vasculature development in zebrafish.
Methods

Zebrafish Breeding and Maintenance
All experiments carried out on animals were performed according to ethical approval granted by the UCD Animal Research Ethics Committee. Zebrafish were maintained in a 14-hour light, 10-hour dark cycle in a recirculating water system at 28 o C and feed brine shrimp twice daily. vhl -/larvae were generated through natural spawning by incrossing vhl hu2117 +/zebrafish on transgenic background Tg(fli1:EGFP) and maintained as previously described [16] .
Genotyping
To identify adult vhl hu2117+/zebrafish, a section of the caudal fin was obtained under anaesthesia (Tricane MS-222) (Sigma Aldrich, UK). DNA was extracted using 50 mM NaOH (Sigma Aldrich, UK) before neutralising with Trizma Base (Sigma Aldrich, UK). The region of interest was amplified by PCR using the following primers which span the vhl mutation site: 5'-TAAGGGCTTAGCGCATGTTC-3' and 5'-CTATCTACGCGTTTAACTCG-3'. PCR products were purified using a PCR clean up kit (New England Biolabs) and the single nucleotide polymorphism identified through sequence analysis (Source Biosciences, Ireland).
Drug Preparation and Treatment
Sunitinib malate (Sigma Aldrich, UK) was added to embryo medium (0.137 M NaCl, 5.4 mM KCl, 5.5 mM Na 2 HPO 4 , 0.44 mM KH 2 PO 4 , 1.3 mM CaCl 2 , 1.0 mM MgSO 4 and 4.2 mM NaHCO 3 ) containing methylene blue. At 58 hpf, embryos were manually dechorionated and 400 µl of increasing test concentrations of sunitinib added to each well containing five embryos in a 48 well plate.
Behavioural Analysis
To measure optokinetic response (OKR), larvae were immobilised in 9% methylcellulose (Sigma Aldrich, UK) and placed in the centre of a rotating drum containing black and white stripes. The drum was rotated at 18 rpm for 30 seconds in a clockwise and 30 seconds in a counter-clockwise direction. Saccades per minute were recorded manually (Deeti et al., 2014) . To measure visual motor response (VMR), individual larvae were added to a square, flat bottomed 96 well plate in 600 µl of embryo medium and placed in a Zebrabox chamber (Viewpoint Life Sciences, France) to record locomotor activity in response to changes in light intensity. Larvae were acclimatised for 1 hour in light followed by 100 minutes of light in 20 minute ON-OFF intervals. Larval movement was quantified using Viewpoint software and data was analysed using a MS Excel spreadsheet as previously described [17] .
Hyaloid Vessel Analysis
5 dpf larvae were fixed in 4% paraformaldehyde overnight at 4 °C and subsequently washed in 1X PBS-0.1% Tween 20 (PBST). Fixed larvae were screened for overall morphological defects before dissecting the lens. The number of eGFP positive primary HV and vessel branches on the lens posterior were quantified using an Olympus SZX16 fluorescent microscope.
Intraretinal blood vessel analysis
Larvae were fixed in 4% PFA overnight at 4 o C. Following 3 PBST washes, samples were transferred to a 5%:20% sucrose gradient before incubating overnight at 4 o C in 20% sucrose.
Samples were washed in 20% sucrose:OCT gradient before OCT embedding and storage at -80 o C. Samples cut to 20 µm sections were counterstained with DAPI. Images were taken using a Zeiss LSM510 confocal microscope (Carl Zeiss AG, Germany) with a 63X objective.
Images were deconvoluted using Autoquant X3 software (Media Cybermetrics, USA) and projections generated using Imaris software (Bitplane, Switzerland). To quantify retinal vasculature, the area of eGFP+ blood vessels (minus the normal hyaloid artery) was manually measured using ImageJ software in sibling and vhl -/samples.
Choriocapillaris development assay
Eggs were collected from Tg(fli1a:EGFP) y1 transgenic zebrafish and fertilization was confirmed at 2-4 hpf. Fertilized eggs were incubated in PTU-containing E3-medium for 58 or 72 hours as indicated and then treated with 0.1% DMSO (vehicle control) or 1 µM sunitinib malate (LC Laboratories) until 120 hpf. The larvae were then euthanized in 0.04% MS-222 (Ethyl 3-aminobenzoate methane sulfonic acid salt 98%, Sigma Aldrich) and fixed in 4% PFA (Sigma Aldrich) for 30 minutes at room temperature. The larvae were enucleated and the eyes dissected using watchmakers forceps (Dumont #5) under a dissection microscope (Nikon SMZ 1500). The retinae and choroids were flat mounted on glass slides in Vectashield mounting medium (H-1000 Vector laboratories) and imaged by confocal microscopy (Zeiss, LSM 700). The number of interstitial pillars (ISPs) were counted manually and used as a measure of the extent of active vascular growth.
Histological Analysis
Larvae were fixed in glass vials containing 2.5% glutaraldehyde, 2% paraformaldehyde and 0.1% Sorenson's phosphate buffer (pH 7.3) and placed at 4 o C overnight. Samples were transferred to 1% osmium tetroxide before an ethanol gradient dehydration. Larvae were embedded in agar epoxy resin and sectioned using a glass knife and a Leica EM UC6 microtome. Sections were placed on glass slides and stained with Toluidine blue (Sigma Aldrich, UK) and imaged using a Leica DMLB bright field illumination microscope with a Leica DFC 480 camera.
Total RNA extraction, cDNA synthesis and qPCR
Approximately 40 pooled larvae were stored in RNAlater (Qiagen) at 5 dpf before the eyes were enucleated and total RNA extracted using mirVana™ miRNA Isolation Kit (ThermoFisher Scientific) as per the manufacturer's instructions. Total RNA concentration was quantified at 260 nm (Spectrophotometer ND 2000) and samples stored at −80°C until further use. cDNA was synthesised using SuperScript II Reverse Transcriptase system To quantify vegfaa, vegfab, vegfc and kdrl expression, 0.5 μ l of Taqman real time assay (Applied Biosystems) was used in each reaction.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism™ software (GraphPad, San Diego, CA). The one-tailed student's paired t-test was used when statistical analysis was required between two experimental groups. For analysis involving more than two independent groups with multiple test doses, a repeated measures one-way ANOVA and Dunnett's multiple comparisons post hoc test was performed. When two variables were compared, a two-way ANOVA was used with Bonferroni post-test. All data are presented as mean ± standard error of the mean (SEM). Statistical significance was assigned to p-values of p < 0.05 = *, p < 0.01 = ** or p < 0.001 = ***.
Results
Characterisation of vhl -/zebrafish
Larvae were examined for key vhl -/phenotypes previously described [13] . Putative vhl -/larvae fail to inflate their swim bladder and display severe yolk and pericardial oedema at both 4 and 5 dpf ( Figure 1 .A). At 5 dpf, larvae from vhl +/incrosses were separated into two groups, predicted unaffected siblings and predicted vhl -/based on these phenotypes.
Sequencing of individual larvae confirmed a complete correlation between phenotype and genotype. 100% of sibling larvae genotyped as vhl +/+ or +/possessed an inflated swim bladder whereas this feature was absent in 100% of larvae genotyped vhl -/- (Figure 1 
vhl -/larvae display retinal and visual function defects
The eye is a metabolically demanding organ [18] . Defects in vhl -/ocular vasculature were hypothesised to result in impaired vision. Two behavioural assays were applied to assess 
vhl -/larvae possess retinal neovascularisation and lack hyaloid vessels at 4 and 5 dpf
To facilitate vasculature imaging, vhl hu2117 zebrafish were crossed into the Tg(fli1:EGFP) y1 line. Characterisation of ocular vessels in whole larvae by imaging through the physiological lens previously identified ectopic ocular vasculature in vhl -/- [14] . To further characterise these vascular defects, ex vivo hyaloid vessel assays were conducted, wherein the lens is dissected from the retina and the number of primary eGFP + blood vessels originating from the central point quantified [19] . Surprisingly, untreated vhl -/larvae contained significantly reduced primary hyaloid branches at 4 dpf (2-fold, p< 0.01) and 5 dpf (10.6-fold, p<0.001) compared to unaffected sibling controls (Figure 3 A-B) . To locate the ectopic ocular vasculature, retinal cryosections were imaged by confocal microscopy. A specific pattern of ectopic intraretinal vascularisation was noted in vhl -/larvae with blood vessels branching throughout the inner plexiform layer at 4 dpf with more extensive growth 24 hours later ( Figure 3 .C). GFP positive areas in the retina, excluding the normal hyaloid artery were quantified by ImageJ. Intraretinal vessel area was significantly increased in vhl -/larvae at both 4 (37-fold, p< 0.01) and 5 dpf (68.2 fold, p< 0.01).
Sunitinib malate significantly improves visual function and reduces VEGF expression in vhl -/larvae
We hypothesised that pharmacological agents known to reduce angiogenesis, oedema, inflammation or neurodegeneration [14, 20, 21] To elucidate molecular processes contributing to improved vhl -/vision, ocular mRNA levels of pivotal pro-and anti-angiogenic regulators were quantified. mRNA expression of all sema3 isoforms in vhl -/eyes, before or after sunitinib treatment, were comparable to sibling control eyes. vegfaa expression is significantly upregulated in vhl -/fish, suggesting it is a driver of the vhl -/phenotype [14] . Although not restored to sibling levels, vegfaa expression was significantly reduced (5.6-fold, p< 0.05) following 1 μ M sunitinib treatment (Figure 4.F) .
In contrast, the expression of vegfab and kdrl are significantly upregulated in the vhl -/eye however expression levels were unchanged by sunitinib treatment (Figure 4 .F) .
Sunitinib malate improves hyaloid vessel patterning, reduces retinal neovascularisation normal and inhibits excessive development of the choriocapillaris in vhl -/larvae.
We hypothesised that restored visual function and reduced ocular vegfaa levels following sunitinib treatment may correlate with improvements in the vhl -/vascular morphology phenotypes. Interestingly, the anti-angiogenic drug did not decrease primary hyaloid branch number. Additionally, while it did not significantly increase primary hyaloid branch number, Interestingly, starting treatment at 58 hpf led to a much more pronounced, anti-angiogenic effect in the choriocapillaris, particularly in the vhl -/larvae ( Figure 5 .D and E).
Discussion
Here, we report original findings on ocular phenotypes in the zebrafish vhl -/model. We demonstrate for the first time, profoundly attenuated visual behaviour in vhl -/larvae. In addition, we prove unequivocally that vhl -/possess extensive ectopic intraretinal vasculature and abnormal hyaloid vessel patterning. These phenotypes occur in parallel with elevated vegfaa levels in the eye. Significantly, treatment with the potent anti-angiogenic agent sunitinib culminated in reduced ocular vegfaa levels, resolved ocular vasculature dysmorphology and restored visual function.
Visual capacity in 4 and 5 dpf vhl -/larvae is significantly reduced when examined by OKR and VMR behavioural assays. We hypothesised that the aetiology of this visual defect was due to ocular vascular phenotypes. Retinal vasculature is absent at 5 dpf in zebrafish [22] .
Instead, at this stage, the eye is nourished by the choroidal and hyaloid vascular networks Previous clinical trials evaluating the use of sunitinib to treat advanced retinal hemangioblastomas documented that treatment did not improve visual acuity or reduce the size of the lesion [32] . Nonetheless, the vhl -/zebrafish model provides a reliable, vertebrate model to study pathological angiogenesis and screen for genes and drug compounds that regulate intraretinal neovascularisation. 
